Business news – Page 49
-
BusinessMerck KGaA to buy Chematica
Retrosynthesis tool will gain computational muscle and integrate with Sigma–Aldrich catalogue
-
BusinessBP to sell Chinese joint venture stake to Sinopec
Oil giant retains significant investment in China, but is shifting focus
-
BusinessRussia invests in speciality chemicals industry
Government will pump cash into sector to develop domestic industry, counteract effects of sanctions, and meet demand from military
-
BusinessIndia probes Roche over biosimilars
Mylan and Biocon claim Roche abused its market dominance to quash generic breast cancer antibodies
-
BusinessFarmers sue to block Syngenta–ChemChina merger
Planned takeover will decrease competition, leading to higher costs and fewer options for farmers
-
BusinessBrexit raises regulatory worries
Risk of doubling legal burden for industry undermines referendum’s ‘red-tape cutting’ claims
-
BusinessChina approves BMS’s hepatitis C drugs
Combination is first all-oral treatment in China, where Gilead’s Sovaldi is not yet approved
-
OpinionCrystal clear
The dark craft of crystallisation is an essential skill when working on kilogram scale
-
BusinessUS university sues Dow over pollution
Three hazardous chemicals have infiltrated campus groundwater, and the school wants Dow and others to pay for clean-up
-
ResearchCatalyst puts chiral twist on phosphorus drugs
Simple molecule overcomes headache of phosphorus stereochemistry in antiviral drug synthesis
-
CareersPeople power: EU chemical workforce and industry turnover
According to the European Chemical Industry Council, the EU chemical industry has a £450 billion turnover and some 1.1 million direct employees
-
OpinionTime to stop using patents to measure innovation in universities
The number of filed patents is a misleading metric for assessing academic research
-
OpinionBuilding business across borders
Internationality is here to stay. Companies need to capitalise on it
-
-
BusinessFresenius to buy Akorn and Merck KGaA’s biosimilars
Deals give Fresenius entry into rapidly growing biological drugs market
-
OpinionAlternate chemical realities
What would chemistry look like if key discoveries had happened differently?
-
BusinessCarbon Clean Solutions and Veolia team up to expand carbon capture and re-use
New partnership will further develop the use of carbon capture technology on industrial scale
-
BusinessHow do chemical firms last hundreds of years?
What distinguishes companies that thrive from others that failed?
-
BusinessOnline tool tracks bio-based materials
E-certificates automatically trace ingredients through supply chain processes
-
BusinessJob cuts at Amgen, Takeda and Vertex
Takeda reorganising following Ariad takeover, while Amgen and Vertex move staff to Cambridge and San Francisco hubs